I. Jolanda de Vries

Mangala Srinivas¹, 

Philipp Boehm-Sturm², 

Markus Aswendt², 

Eberhard D. Pracht^2,3, 

Carl G. Figdor¹, 

I. Jolanda de Vries¹, 

Mathias Hoehn² 

¹Department of Tumor Immunology, Nijmegen Center for Molecular Life Sciences, Radboud University Medical Center, 

²In-Vivo-NMR Laboratory, Max Planck Institute for Neurological Research, 

³, German Center for Neurodegenerative Diseases (DZNE)